CFTR Modulators in Pregnancy and Postpartum
Recruiting
- Conditions
- Cystic Fibrosis
- Registration Number
- NCT06302270
- Lead Sponsor
- Region Stockholm
- Brief Summary
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Woman with cystic fibrosis who is pregnant and treated with Kaftrio. Newborn infant to the above mentioned woman
Exclusion Criteria
none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health effects in the newborn infant 6 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stockholm CF center
🇸🇪Stockholm, Sweden